- Home
- ATER vs PTHL Comparison
ATER vs PTHL Comparison
Compare ATER & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATER | PTHL |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Home Furnishings | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 8.8M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | ATER | PTHL |
|---|---|---|
| Price | $0.91 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 216.1K | 61.3K |
| Earning Date | 11-13-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $78,450,000.00 | $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $0.42 |
| 52 Week High | $3.50 | $32.00 |
Technical Indicators
Market Signals| Indicator | ATER | PTHL |
|---|---|---|
| Relative Strength Index (RSI) | 63.96 | 42.76 |
| Support Level | $0.64 | $0.42 |
| Resistance Level | $0.82 | $0.50 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 100.00 | 53.85 |
Price Performance
Historical ComparisonAbout ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.